Company intelligence / Profile preview

Genuine Research Center

Ownership: Private
Employees: ~32
Development stage: Commercial

Overview

Genuine Research Center is Egypt’s leading full-service contract research organization specializing in bioequivalence studies, comparative dissolution, stability testing per ICH guidelines, pharmacovigilance, and phase II–IV clinical trials. The company is recognized for high-quality standards in pharmaceutical drug development support.

It has conducted numerous bioequivalence and biowaiver studies as well as clinical trials across multiple countries.

Modalities: Small moleculeGeneric drugs
Industry: Contract Research Organization

Partnerships

Not specified publicly.

Beyond the preview

Go deeper on Genuine Research Center.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genuine Research Center.

Explore the full profile